152 related articles for article (PubMed ID: 9416484)
1. Expression of c-Met correlates with grade of malignancy in human astrocytic tumours: an immunohistochemical study.
Nabeshima K; Shimao Y; Sato S; Kataoka H; Moriyama T; Kawano H; Wakisaka S; Koono M
Histopathology; 1997 Nov; 31(5):436-43. PubMed ID: 9416484
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical examination of c-Met protein expression in astrocytic tumors.
Hirose Y; Kojima M; Sagoh M; Murakami H; Yoshida K; Shimazaki K; Kawase T
Acta Neuropathol; 1998 Apr; 95(4):345-51. PubMed ID: 9560011
[TBL] [Abstract][Full Text] [Related]
3. Secreted protein, acidic and rich in cysteine (SPARC) expression in astrocytic tumour cells negatively correlates with proliferation, while vascular SPARC expression is associated with patient survival.
Capper D; Mittelbronn M; Goeppert B; Meyermann R; Schittenhelm J
Neuropathol Appl Neurobiol; 2010 Apr; 36(3):183-97. PubMed ID: 20132490
[TBL] [Abstract][Full Text] [Related]
4. Expression of hepatocyte growth factor/scatter factor and its receptor c-Met in brain tumors: evidence for a role in progression of astrocytic tumors (Review).
Moriyama T; Kataoka H; Koono M; Wakisaka S
Int J Mol Med; 1999 May; 3(5):531-6. PubMed ID: 10202187
[TBL] [Abstract][Full Text] [Related]
5. Expression and localization of scatter factor/hepatocyte growth factor in human astrocytomas.
Kunkel P; Müller S; Schirmacher P; Stavrou D; Fillbrandt R; Westphal M; Lamszus K
Neuro Oncol; 2001 Apr; 3(2):82-8. PubMed ID: 11296484
[TBL] [Abstract][Full Text] [Related]
6. Met and hepatocyte growth factor/scatter factor expression in human gliomas.
Koochekpour S; Jeffers M; Rulong S; Taylor G; Klineberg E; Hudson EA; Resau JH; Vande Woude GF
Cancer Res; 1997 Dec; 57(23):5391-8. PubMed ID: 9393765
[TBL] [Abstract][Full Text] [Related]
7. Correlation of glial fibrillary acidic protein (GFAP) with grading of the neuroglial tumours.
Reyaz N; Tayyab M; Khan SA; Siddique T
J Coll Physicians Surg Pak; 2005 Aug; 15(8):472-5. PubMed ID: 16202357
[TBL] [Abstract][Full Text] [Related]
8. Receptor tyrosine kinase expression in astrocytic lesions: similar features in gliosis and glioma.
Kristt DA; Reedy E; Yarden Y
Neurosurgery; 1993 Jul; 33(1):106-15. PubMed ID: 7689190
[TBL] [Abstract][Full Text] [Related]
9. Comparative analysis of expression of hepatocyte growth factor and its receptor, c-met, in gliomas, meningiomas and schwannomas in humans.
Moriyama T; Kataoka H; Kawano H; Yokogami K; Nakano S; Goya T; Uchino H; Koono M; Wakisaka S
Cancer Lett; 1998 Feb; 124(2):149-55. PubMed ID: 9500204
[TBL] [Abstract][Full Text] [Related]
10. Trk A, B, and C are commonly expressed in human astrocytes and astrocytic gliomas but not by human oligodendrocytes and oligodendroglioma.
Wang Y; Hagel C; Hamel W; Müller S; Kluwe L; Westphal M
Acta Neuropathol; 1998 Oct; 96(4):357-64. PubMed ID: 9797000
[TBL] [Abstract][Full Text] [Related]
11. Apoptosis and proliferation: correlation with p53 in astrocytic tumours.
Sarkar C; Karak AK; Nath N; Sharma MC; Mahapatra AK; Chattopadhyay P; Sinha S
J Neurooncol; 2005 Jun; 73(2):93-100. PubMed ID: 15981097
[TBL] [Abstract][Full Text] [Related]
12. Hepatocyte growth factor (HGF) and receptor (c-met) in normal and malignant astrocytic cells.
Welch WC; Kornblith PL; Michalopoulos GK; Petersen BE; Beedle A; Gollin SM; Goldfarb RH
Anticancer Res; 1999; 19(3A):1635-40. PubMed ID: 10470094
[TBL] [Abstract][Full Text] [Related]
13. Correlation of aquaporin-1 water channel protein expression with tumor angiogenesis in human astrocytoma.
El Hindy N; Bankfalvi A; Herring A; Adamzik M; Lambertz N; Zhu Y; Siffert W; Sure U; Sandalcioglu IE
Anticancer Res; 2013 Feb; 33(2):609-13. PubMed ID: 23393355
[TBL] [Abstract][Full Text] [Related]
14. Expression of tenascin-C in astrocytic tumors: its relevance to proliferation and angiogenesis.
Kim CH; Bak KH; Kim YS; Kim JM; Ko Y; Oh SJ; Kim KM; Hong EK
Surg Neurol; 2000 Sep; 54(3):235-40. PubMed ID: 11118570
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical analysis of cyclin A in astrocytic tumours.
Chakrabarty A; Bridges LR
Neuropathol Appl Neurobiol; 1998 Jun; 24(3):239-45. PubMed ID: 9717190
[TBL] [Abstract][Full Text] [Related]
16. Expression of vascular endothelial growth factor and its receptors in the anaplastic progression of astrocytoma, oligodendroglioma, and ependymoma.
Chan AS; Leung SY; Wong MP; Yuen ST; Cheung N; Fan YW; Chung LP
Am J Surg Pathol; 1998 Jul; 22(7):816-26. PubMed ID: 9669344
[TBL] [Abstract][Full Text] [Related]
17. hTERT immunopositivity patterns in the normal brain and in astrocytic tumors.
Kotoula V; Cheva A; Barbanis S; Papadimitriou CS; Karkavelas G
Acta Neuropathol; 2006 Jun; 111(6):569-78. PubMed ID: 16614861
[TBL] [Abstract][Full Text] [Related]
18. [The expression of hepatocyte growth factor and its receptor in brain astrocytomas].
Chu SH; Yuan XH; Jiang PC; Li ZQ; Zhang J; Wen ZH; Zhao SY; Chen XJ; Cao CJ
Zhonghua Yi Xue Za Zhi; 2005 Mar; 85(12):835-8. PubMed ID: 15949402
[TBL] [Abstract][Full Text] [Related]
19. Correlation of endothelial nitric oxide synthase and vascular endothelial growth factor expression with malignancy in patients with astrocytic tumors.
Erdamar S; Bagci P; Oz B; Dirican A
J BUON; 2006; 11(2):213-6. PubMed ID: 17318973
[TBL] [Abstract][Full Text] [Related]
20. Occurrence of ganglioside GD3 in neoplastic astrocytes. An immunocytochemical study in humans.
Kawai K; Takahashi H; Watarai S; Ishizu H; Fukai K; Tanabe Y; Nose S; Kuroda S
Virchows Arch; 1999 Mar; 434(3):201-5. PubMed ID: 10190298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
